We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




New Technique Reduces Loss of MicroRNAs from Biological Specimens

By LabMedica International staff writers
Posted on 16 Feb 2009
A recent publication described the development of a technique for preventing microRNAs, small regulatory RNAs with many biological functions and disease associations, from leaking from biological specimens during fixation. More...


Usually biological specimens such as tissues or cells are treated with a cross linking agent such as formaldehyde to fix molecules in place. The agent locks the specimen's macromolecules into a type of minute scaffolding, but as explained by first author Dr. John Pena, assistant professor of molecular biology at the Rockefeller University (New York, NY, USA), "Because microRNAs are so small, they come out of the tissue. They just fall through the scaffold."

Dr. Pena and his colleagues reported in the January 11, 2009, online edition of the journal Nature Methods that the loss of microRNAs from formaldehyde-fixed tissues could be prevented by subsequent fixation with 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC). This treatment irreversibly immobilized the microRNA at its 5' phosphate end.

They tested this method on more than 130 microRNAs in an assortment of tissues including heart, liver, muscle, and brain. Results showed that retention of microRNAs by tissues treated with formaldehyde and EDC was consistently greater than in tissues treated with formaldehyde alone.

"If microRNAs are going to be used as a diagnostic tool, we need a reliable way to measure them in normal and disease tissue, regardless of where or to what degree they are expressed," said Dr. Pena. "So that is what we did: We went back and examined and questioned every single step of this protocol to see where we could optimize it. In order to move forward, we had to go to the basics."

Related Links:
Rockefeller University



Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Spinal Fluid Cell Count Control
Spinalscopics
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.